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Abstract--In this article, an Expert System for Homeopathic Glaucoma Treatment (SEHO) is pre- 
sented, the task of which is to assist ophthalmologists in selecting the most appropriate therapy for a 
patient diagnosed as having glaucoma. It is based on techniques proper to homeopathic medicine, a
trend that is gaining more and more supporters all over the world, but in which real experts are few 
and far between. After a brief overview of the state of the art, the authors describe in detail on the 
development ofthe system, for which the IDEAL methodology, designed for knowledge-based system 
development, was used. 
1. INTRODUCTION 
LAMENTABLY, GLAUCOMA is one of the most signifi- 
cant pathologies affecting sight, the number of cases 
making it one of the major visual disorders. This disease 
often leads to irreversible blindness and is accompanied 
by an inherited traumatic process, making glaucoma 
sufferers especially sensitive to the methods used in 
their treatment. 
A marked partiality toward the field of alternative 
medicine has been observed within the blind com- 
munity, on some occasions as a complement to tra- 
ditional medicine and on others due to their openness 
to and acceptance of these branches of medicine, of 
which homeopathy is a clear example, which they con- 
sider to be less aggressive. 
Homeopathic medicine is based on the activation 
of the organism's healing mechanisms by administering 
homeopathic dilutions corresponding tospecific doses 
of these medicines. 
It should not be forgotten that a blind person faces 
other problems besides ight impairment, such as dif- 
ficulties in social integration, adaptation, and mobility, 
etc., as well as other underlying illnesses which in many 
cases originally induced the process leading to blind- 
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ness. As a result, these people can hardly be treated 
medically without their physical and mental charac- 
teristics being taken into account. 
Homeopathy is in fact oriented in this direction, 
and, as far as visual disorders are concerned, homeo- 
pathic treatment depends on four factors (Rubio, 1988): 
the threat o vision, the kind of disorder and manner 
in which it evolves, the level of individual sensitivity, 
and the subject's potential for response. 
And such treatment is composed of 
• Remedies prescribed for local symptoms, and 
• Remedies for the glaucomatous field (patient's phys- 
ical and mental constitution). 
The secretion of aqueous humour (an important 
factor in glaucoma) isclosely linked with the sensitivity 
of the neurovegetative system and that the stress of 
everyday life and emotions affect pressure in the eye- 
ball. Psychological tests have revealed that glaucoma 
sufferers are anxious, susceptible, and meticulous and 
that the glaucomatous subject's hypersensitivity affects 
the treatment of the patient. Homeopathic treatment 
is very often associated with traditional therapies, often 
permitting a reduction in the dosage and an increase 
in the patient's tolerance to the latter. So, we can say 
that the different herapies, far from being opposed to 
each other, are complementary, or as Blamentier states 
(Rubio, 1988), "it is the patients and not the therapies 
that differ." 
It is important to observe how sensitive the patient 
is to a therapy that stimulates his defence potential. 
However, it is not easy to appreciate this potential, as 
it depends on many factors, such as age, the degree of 
sensitivity of the lesions, and the patient's character- 
istics and constitutional data. These make it possible 
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for the homeopathic doctrine and clinical expertise to 
decide what is the most suitable treatment. 
However, it is not possible to establish a general rule 
to cover the wide range of possibilities that crop up in 
the homeopathic doctor's urgery and, at all events, 
the only suitable guide he or she has personal experi- 
ence. Therefore, it was thought necessary to employ 
knowledge ngineering techniques to deal with this 
problem. This led to the development of the expert 
system described, which was developed at CETTICO 
(Centre of Technology Transfer in Knowledge Engi- 
neering) and is able to assign homeopathic treatment 
to glaucoma sufferers. 
There are no similar expert systems on record. Vi- 
sual disorders have been little dealt with in the past, 
and the therapy model has always been based on al- 
lopathic medicine. The CASNET system (Kulikowski 
& Weiss, 1982), oriented to the diagnosis and treatment 
of different kinds of glaucoma, is an example of this. 
In addition, there is a knowledge gap in homeopathic 
glaucoma treatment, due both to the lack of experts in 
this kind of therapy and to the fact that they are con- 
centrated in half a dozen countries. 
Therefore, the system entails a qualitative advance 
in the treatment ofthe blind, bringing innovative tech- 
niques into an alternative approach to medicine that 
is held in high esteem by the blind community. 
2. COMPUTER SYSTEMS IN 
HOMEOPATHIC MEDICINE 
Until recently, the computer models used to simulate 
medical decision making in a computer system have 
been mainly based on probabilistic methods, as their 
machine representation is easy to obtain (Gorry, Sil- 
verman, & Pauker, 1978; Solomon & Papert, 1976). 
Despite the fact that these programs have come up 
with very interesting results, the doctor does not iden- 
tify his or her reasoning and manner of arriving at a 
diagnosis with theirs, and it is also difficult o evaluate 
the quality of a diagnosis proposed in this way. 
In addition, it has been noted (Ledley & Lusted, 
1979) that the majority of clinical errors are made by 
omission, that is, errors due to a failure to take into 
account all of the possibilities playing an important 
role in determining the illness suffered by the patient 
so as to arrive at the correct diagnosis and treatment. 
Therefore, a doctor needs assistance inestablishing the 
diagnosis and a suitable therapy, especially in the case 
of unusual illnesses or when the patient's ymptoms 
may lead to different interpretations. Considering that 
all of the information required on a patient can be 
stored and classified in a computer, along with the 
symptoms of the illnesses of a domain, it follows that, 
in such circumstances, a computer may come up with 
a more precise and rapid response than a doctor (Barr 
& Feigenbaum, 1982), especially when the knowledge 
of the symptoms of an illness has been elicited from 
an expert doctor and incorporated into a knowledge 
base that interacts with an expert system. 
A complete and adequate homeopathic study of a 
patient depends on the skill of the homeopath and his 
or her ability in identifying, storing, recording, refer- 
encing, analysing and evaluating any class of data or 
group of data. This requires a system of classification, 
according to which the concepts and relevant infor- 
mation are organized, and a coding, which facilitates 
their use. 
Originally, the homeopath's traditional prescription 
and, later, data bases, which were and are of great help 
in homeopathic surgeries, were used for classification 
and coding. However, it has been noted on several oc- 
casions that doctors are generally somewhat reluctant 
to use computers as a tool and consider them to be 
little suited to establishing repertories, that is, what 
medicines cover the patient's symptoms, the number 
of symptoms, and to what extent. 
On the other hand, medical reasoning is related to 
judgement problems, problem solving, decision mak- 
ing, and knowledge (Fieschi, 1987), which is why it has 
come to be a traditional working domain in knowledge 
engineering. 
The introduction of ES into medical diagnosis and 
treatment has done away with initial scepticism, and 
they have come into more widespread use. Examples 
of this are MYCIN (Shortliffe, 1976), TEIREISIAS 
(Davis, 1976), INTERNIST (Pople, 1977), PIP (Pauker 
& Szolovitz, 1977), DIGITALIS THERAPY ADVI- 
SOR (Gorry et al., 1978), CENTAURI (Aikins, 1980), 
SAM (Gascuel, 1981), ATTENDING (Miller, 1988), 
CASNET (Kulikowski & Weiss, 1982), NESTOR 
(Cooper, 1984), KARDIO (Bratko, 1989). 
Unfortunately, however, few ES have gained access 
to homeopathic surgeries, though several computer 
systems based on this alternative medicine have been 
developed, such as the following. 
• RADAR (Shrogens, 1982), which contains everal 
pharmacopoeias, including those by Allen, Hering, 
Heneman, and Boerick. It has access to 2,000 ho- 
meopathic remedies and their corresponding phar- 
macopoeias. 
• HINEIRO (Bachelerie, 1986) contains 2,535 Boen- 
ninghausen therapy rubrics (symptoms). Each of 
these rubrics is associated with a blackboard with the 
most common remedies. 
• ABIES (Benson, 1980) is a clinical information sys- 
tem. In addition to carrying out medical treatment, 
it locates notes and treatments for patients using the 
RCC system (Real Clinical Classification) (Read & 
Benson, 1986), which is a hierarchical statistical 
classification of a nomenclature with four detail 
levels. 
• STAPHISE (SalaiJn & Simonet, 1989), an infor- 
mation system using the Ken repertory, composed 
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of some 20,000 rubrics taken from different phar- 
macopoeias. Its information base may be custom- 
ized. 
As regards ES in homeopathic medicine, we should 
mention VES (Vithoulkas, 1988), developed by the 
homeopath George Vithoulkas. His working philoso- 
phy can be situated within the unitarian current of 
homeopathy. The VES system returns the best remedy 
with a given scoring and certainty factor, indicating to 
what extent any alternative r medies presented can be 
administered. VES is integrated into the RADAR sys- 
tem and takes advantage ofits potential. It is a general 
medical application and is not specialized in any class 
of illness. 
3. SEHO (ES FOR HOMEOPATHIC 
GLAUCOMA TREATMENT) 
Considering homeopathy ascomplementary to tradi- 
tional treatments ofvisual disorders causing blindness 
and taking into account i s acceptance among the blind 
community, it was thought necessary to research and 
develop an ES to treat glaucoma. This would assist he 
homeopath in inference tasks and, finding the medi- 
cines most suited to each patient, would come up with 
the appropriate dilutions. The end result was the pro- 
totype system SEHO (Cristrbal & Ortiz Latierro, 1991). 
As opposed to other systems, NEOMYCIN for ex- 
ample, which mainly use the description of the patient's 
illness to select he therapy (Clancey, 1981; Clancey & 
Shortliffe, 1984), SEHO compiles extensive and com- 
plete information on the patient through omeopathic 
questioning before suggesting any remedy and thus 
does not point the doctor in any particular direction 
that might lead him or her to overlook important data 
on the patient during the session. 
The results of the questioning session are sent o the 
homeopathic techniques of the expert, which attempts 
to put together the most complete profile of the patient 
possible and to establish is or her characteristics and 
symptoms so as to apply the most suitable medicines. 
Optionally, the system can provide information on 
other possible, though less suited, medicines together 
with the patient's symptoms that each of them covers. 
Like other ES, SEHO provides information on its 
reasoning process, explaining the intermediate conclu- 
sions and why it selects and incorporates ach medicine 
into the working memory. 
There are two different trends in homeopathic med- 
icine: the unitarian trend, which suggests only one 
medicine as a remedy (e.g., VES) and the pluralist 
trend, to which SEHO belongs, which proposes differ- 
ent dilutions of several medicines. So, SEHO's dilutions 
contain several medicines. 
SEHO is, therefore, the first ES for treating avisual 
disorder from the point of view of alternative medicine. 
Another important characteristic differentiating it from 
other systems i  the fact that it has been designed to 
be used by the blind, available Braille adaptations hav- 
ing been incorporated into the prototype system. Its 
line of reasoning, based on the techniques ofthe chosen 
expert, the Chairman of the Association of Homeo- 
paths of Madrid, leads to scaled dilutions, that is, to 
the assignation of three or more medicines in most 
cases, some with low, some with intermediate, and 
others with high dilutions, except when any of these 
are superfluous. 
The inference process passes through several stages 
before arriving at these recommendations. The first 
stage, medicine determination, covers all of the pa- 
tient's symptoms, both those related with specific 
symptoms and their field characteristics. It selects the 
lowest possible number of the most suited medicines. 
Provisional dilutions are assigned in the second stage, 
and the scaled ilutions are established in the final one. 
SEHO was developed using GURU, and its knowl- 
edge base is composed of seven rule bases, which con- 
tain a total of 72 rules based on public and expert 
knowledge on glaucoma, nd five data bases, contain- 
ing medicines and symptoms, categories and field. Its 
inference mechanism is backward chaining. 
The prototype has been designed in such a way that 
its knowledge base and data bases, containing phar- 
macopoeias including the latest findings with respect 
to homeopathic remedies for glaucoma, can be ex- 
panded. 
4. SPECIFICATION AND DEFINITION OF 
SEHO 
The IDEAL methodology (Mat6 & Pazos, 1988), one 
of the most prestigious methodologies for ES devel- 
opment today, was used to define and develop the pro- 
totype system. This methodology brings together the 
most relevant ones in this area. Some of these meth- 
odologies are (Hayes-Roth, Waterman, & Lenat, 1983; 
Liebowitz & De Salvo, 1989; Waterman, 1986). 
Requirements definition was based on the following 
general concepts: 
• Interface faithfully reflecting the content and extent 
of homeopathic questioning on the patient's char- 
acteristics and constitutional data and his or her 
symptoms, and adapted for the blind. 
• Storage of complete pharmacopoeias on each med- 
icine. 
• Assignation of scaled ilutions of the remedies in the 
final treatment: low (4 CH), intermediate (7 CH), 
and high (15 CH) dilutions. 
• Assignation of the smallest possible number of nec- 
essary medicines. 
The adequacy test was carried out to evaluate the 
application, and the characteristics were grouped in 
four dimensions according to the IDEAL methodology: 
plausibility, justification, success, and adequacy, using 
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Dimension 
TABLE 1 
Evaluation of the Application 
Dimension Value 
(geometric mean) (Vci) 
Maximum Dimension Value 
(geometric mean) (Vcmi) 
Plausibility 62 89.1 
Justification 29.8 64.1 
Adequacy 48.4 61.9 
Success 46.8 66.5 
t=4 
Vg (General value) = ~ Vci/4 = 46.75. 
I=1 
1=4 
Vm (Maximum value) = ~ Vcmi/4 = 70.4. 
i=1 
Vf (Final application value) = V~ x 10 = 6.64 > 5. 
variable threshold values to accept or reject a charac- 
teristic and the geometric mean (Mat6, 1988; Pazos, 
1989) to evaluate the task. The application was found 
to be suitable for treatment using an ES (threshold val- 
ues of 6.64 > 5) (Table 1). 
SEHO is a decision support system for assigning 
homeopathic resources or remedies, which was con- 
sidered central for its definition. There is an essential 
difference in the method used for assigning the appro- 
priate treatment: it does not directly take account of 
the patient's pathology or type of glaucoma, as allo- 
pathic medicine would; the disease's manifestation is 
truly decisive, that is, the patient's ymptoms and con- 
dition are determined by his or her field characteristics. 
SEHO exclusively considers the symptoms typical 
of glaucoma nd the psychological profile and personal 
factors of the subjects uffering from glaucoma. Surgical 
affections are excluded from this framework, though 
complementary treatment or therapy to improve tol- 
erance to allopathic medicines may be assigned. Figure 
1 shows the flow chart of the SEHO prototype. 
There are two types of knowledge implemented in
the system: 
• Public knowledge, based on homeopathic pharma- 
copoeias (Barraza, 1980; Lathoud, 1988) in 5 data- 
bases, including lists of medicines along with specific 
symptoms, the categories and the field, as well as a 
list of antagonistic categories. 
• Expert knowledge, contained in 7 production rule 
bases, elicited from the expert and based on the op- 
erative and heuristic procedure used by the expert 
himself to prepare treatment. The rules will be fired 
using a backward chaining control strategy, until all 
the premises in its antecedent are true or false. 
• The response time has to be short (less than 5 min- 
utes). 
• During execution, the system offers information on 
the medicines that are being considered to cover the 
symptoms, category, and field, as well as comments 
on how it arrives at the scale of dilutions. 
• Once executed, the system offers information on 
medicines in the final solution, the dilution in which 
the medicine should be administered, osage, length 
of the treatment until the next visit, symptoms and 
characteristics that the selected medicines cover, and 
medicines elected that are not included in the so- 
lut ion along with a list of the symptoms that they 
cover. 
An ideal solution is one that assigns a scaled ilution 
or a single medicine per dilution. This ideal situation 
does not necessarily have to occur in every case: this 
depends on the patient and his or her characteristics. 
5. CONCEPTUALIZATION AND 
FORMALIZATION OF SEHO 
Knowledge acquisition for the conceptualization a d 
subsequent formalization of the knowledge base was 
based on nonstructured interviews in the first stage. 
Cases were presented to the expert and the protocol 
was analysed uring this process in the second stage. 
In the final stage, very explicit structured interviews 
were a means of solving the problems that arose. 
It was found that a homeopath views a patient from 
three different but complementary angles, when estab- 
lishing a therapy: 
• Specific or local symptoms, related with the organ 
or organs affected by the illness (eyes, in the case of 
glaucoma). Symptoms uch as congestive phenom- 
ena, increase in ocular pressure, sight impairment, 
alteration of the optical nerve, etc. 
• Categories, as a means of classifying the symptoms. 
They specify the improvements or deterioration of 
a symptom or of the patient in general. 
• Field, which establishes how the patient reacts to the 
illness and which is characterized by the patient's 
characteristics: physical, mental, and constitutional 
data, such as anxious, susceptible, meticulous, for 
example. 
The result was the conceptual model shown in Fig- 
ure 2 and the knowledge map shown in Figure 3. 
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PATIENT 
1 1 1 
I 
I sY  T° S I 
 I ATIENTI I I MEDICINE , ,  
SYMPTOMS SYMPTOMS I I 
CATEGORY n ~  
I PAT1ENT CATEGORY I I MEDICINE CATEGORY I 
FIELD I~ 
n I I n 
I PATIENT 
MEDICINES I 
FIGURE 2. Conceptual model. 
Knowledge formalization required that a distinction 
be made between two stages in the expert process: 
medicine determination and dilution assignment. 
5.1. Selection of Medicine 
Before medicines are selected, the patient's ymptoms 
are elicited through questioning on individual symp- 
toms, establishing their importance or otherwise, and 
on the patient's categories and fields. 
Considering the 
x ,y ,z  
SI(x) 
nSI(x) 
n MOD(x) 
n MOSANTA(x) 
n SNI(x) 
n TOTSINT(x) 
ST(x) 
A 
B 
following definitions: 
Medicines 
Set of important symptoms cov- 
ered by medicine x
Number of important symptoms 
covered by medicine x
Number of categories covered by 
medicine x
Number of antagonistic categories 
of medicine x
Number of unimportant specific 
symptoms covered by medicine x
Total number of symptoms cov- 
ered by x (specific + category + 
field) 
Set of field symptoms covered by 
x 
Set of medicines elected for spe- 
cific symptoms. It changes as rules 
are fired and some medicines are 
selected and others excluded. At 
the beginning of the process, the 
set covers any important symptom. 
Set of medicines elected for the 
field. Like A, it changes when rules 
are fired. It initially covers any of 
the patient's characteristics or 
symptoms. 
I Patient Name 
A Name 
Category Name 
A Pharmacopoeial 
Category 
1 
Med. Cat. Name 
Category Name 
Medicine Name 
Field Name 
Field Present in
Pharmacopoeia 
Name, Symptom 
Importance 
Name. Important 
Name. Unimportant 
Symptom Name 
" ' "~1 Name 
Symptom Name 
Medicine 
Symptom Name 
Medicine Name 
I Medicine N. Dilution / 
] 
I Med. F. Name I 
" j  ~v~e~c?aernI~la me I
FIGURE 3. Knowledge map. 
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• The procedure followed by the expert for selecting 
the medicine to cover given symptoms is based on 
the following rules: 
If  x, y ~ A and SI(x) C SI (y), then select y 
If  x, y ~ A and SI(x) = SI (y) and nMODANTA(x) 
> nMODANTA(y), then select y 
If  x, y E A and SI(x) = SI (y) and nMOD(x) > 
nMOD(y), then select y 
If x, y ~ A and SI(x) = SI(y) and nSNI(x) > nSNI(y), 
then select x 
If  x, y ~ A and SI(x) = SI (y) and nST(x) > nST(y), 
then select x. 
The obtention of the minimum set in A is based on 
the rules below: 
If  x, y E A and [x,y] covers the symptoms of Ix, y, 
z], then A = A - [z]. 
If there is more than one minimum set, select the 
one whose medicines cover more, important symp- 
toms. 
• The selection of medicines for the field is centered 
on the following rules: 
If x, y E B and ST(x) C ST(y), then select y 
If x, y @ B and ST(x) = ST (y) and nTOTSINT(x) 
> nTOTSINT(y), then select x. 
The obtention of the min imum set in B is based on 
the same rules as for the obtention of the minimum 
A, that is: 
If x, y, z E B and [x, y] covers the symptoms of [x, 
y, z], then B = B - [z]. Select he minimum set that 
covers more, important symptoms. 
5.2.  Ass ignat ion  of  D i lu t ions  
The goal pursued in this stage is the assignment of 
scaled dilutions. First a provisional assignment of the 
dilutions of the medicines obtained is taken, and the 
case-related opt imum is sought. 
If: 
MH Set of high-dilution medicines 
ML 
nH 
nL 
ML1 
ML2 
nLi 
MH1 
MHi  
nHi 
Set of low-dilution medicines 
Number of medicines in MH 
Number of medicines in ML 
Set of medicines in ML that cover categories 
Set of MLI  medicines that cover most cate- 
gories 
Number of MLi medicines with i = l, 2. 
Set of MH medicines that cover field symptoms 
Set of MH l medicines that cover most symp- 
toms (i -- 2. • .9) 
Number of MHi  medicines with i = l • • • 9. 
The provisional dilutions are assigned according to the 
following rules: 
If  x E A and x E B, assign a low dilution to x and x 
@ ML 
If x E A, assign a low dilution to x and x E MH 
I fA :~ 0 and B 4 = 0, then provisional dilutions -- low 
I fB :~ 0 and ML v ~ 0, then provisional dilutions = low 
and high 
IfA = B and B ~ 0 and A ~ 0, then provisional dilutions 
= high 
The different paths taken to arrive at the goal (the suit- 
able dilution), once the provisional dilutions have been 
obtained, are represented in the shape of a tree in Fig- 
ures 4, 5, and 6. 
The final treatment is based on the following rules: 
If  x is assigned a low dilution, prescribe 3 doses of a 
4CH dilution of x per day. 
If x is assigned an intermediate dilution, prescribe 4 
doses o fa  7CH dilution o fx  per day. 
If  x is assigned a high dilution, prescribe 5 doses of a 
15CH dilution o fx  per day. 
6. SEHO SYSTEM IMPLEMENTATION 
The system prototype has been implemented using 
GURU as a development tool. In addition, an interface, 
incorporating a voice synthesizer and Braille line, has 
been designed to enable the blind to use the system. 
PROVISIONAL DILUTIONS = LOW [ 
nL = 1 nL>l 
/ 
nL1 >_ 1 [ 
/ 
nL> 1 
I R14 
Intermed, Dil, 
] nL2>l 
J RI5 
] [Intermed. Dil. 
I x., 
I nL1 = 1 ] 
R16 R17 
FIGURE 4. Dilution assignation I. 
i INoc"an e'iodi' I bchaogesindi' I 
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PROV. DILUTIONS = HIGH I 
FIGURE 5. Dilution assignation II. 
Its design and implementation matches the Struc- 
tures Map in Figure 7, in which the modules describe 
the following actions: 
MSINS Generates the interface for recording 
patients' ymptoms 
MMODS Generates the category interfaces 
MTERRS Generates the field interfaces 
MLEESIN Searches the data base for medicines 
that cover any patient symptom 
MLEEMOD Searches the data base for medicines 
that cover any patient category 
MLEETERR 
ORDENA 
MINIMOSA 
ORDENB 
MINIMOSB 
MBUSDILU 
MDILBYA 
Searches the data base for medicines 
that cover any patient field 
Obtains final medicines for particular 
symptoms 
Obtains minimum sets of medicines 
for symptoms 
Obtains final medicines for field 
Obtains minimum sets of medicines 
for field 
Defines provisional dilution 
Defines uitable dilution 
I PROV. DILUTIONS = HIGH & LOW I 
/ 
FIGURE 6. Dilution assignation III. 
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MRESULT Assigns the most appropriate treat- 
ment, including medicines, their di- 
lutions, and the way of administering 
them. 
7. EVALUATION 
SEHO was evaluated in three phases in line with tra- 
ditional methodological orientations. 
7.1. Validation of System Decisions by the Expert 
Fifteen test cases that had been selected by the expert 
and set out in the project success criteria, along with 
another 20 of the most frequent cases put forward by 
the expert were used for this purpose. Of the examples 
selected, 10% were extreme cases and generated arti- 
ficially, 10% were ambiguous, and the remaining were 
typical cases. The expert approved the system's pro- 
cedure in all of the cases. 
As regards dilution assignation, the different mod- 
ules were verified as follows. 
TABLE 2 
Typical Case, Case No. 6 
SS (Specific Symptoms) 
Nebulas 
Photophobia 
Orbital pain 
Reduced vision 
Dilated pupils 
Stigmata on the cornea 
Categories 
Worsens when lying down 
Worsens in the morning 
Worsens with changes in the 
weather 
Improves in the open air 
Improves with warmth 
FT (field symptoms or 
characteristics) 
Depression 
Obesity 
Apathy 
Pessimism 
Shyness 
Skin irritations 
Fatigue 
Constipation 
Egotism 
Recommended medicines 
FLUORIC CALCAREA--Iow 
dilution 
SULPHUR--intermediate dilution 
CARBONIC CALCAREA--high 
dilution 
CAUSTICUM--high dilution 
Optimal treatment with 
GELSEMIUM--only high 
NUX VOMICA--only high 
AURUM METALICUM~only high 
COMOCLADIA~only high 
Important (I) 
Unimportant (U) 
I 
I 
I 
I 
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A) Step from provisionally low dilutions to low and 
intermediate dilutions 
B) Step from provisionally high dilutions to low and 
high dilutions 
C) Step from provisionally low and high dilutions to 
low, intermediate, and high dilutions. 
It was found that, as required by the expert, the dilu- 
tions are not fully scaled in two situations: 
• When there are no field characteristics and, therefore, 
low dilutions are not assigned; 
• It is impossible to assign intermediate dilutions on 
the basis of high and low dilutions, as the set of med- 
icines counted in this case is equal to the total. This 
case is considered extreme. 
Finally, it was found that the number of medicines 
assigned with a given dilution is never greater than 2, 
just as the expert stipulated. 
A typical case is illustrated in Table 2, indicating the 
form they take. 
7.2. Validation of Typical Cases by Experts Not 
Involved With System Development 
Fifteen typical cases were put to them, and they only 
disagreed on one ambiguous case. This was due to the 
fact that there were two equally acceptable forms of 
treatment, and this was therefore a question of pref- 
erences. Moreover, the system had indicated the second 
possibility as an optional treatment. 
The system has now been transferred tothe Spanish 
National Organization for the Blind (ONCE) as an aid 
for therapists not specialized in homeopathic medicine. 
8. FUTURE RESEARCH WORK 
Although the results provided by SEHO are an im- 
portant advance in the automated treatment of glau- 
coma using homeopathic techniques, we should not 
overlook the fact that SEHO is a prototype requiring 
further development. 
This will involve two courses of action: one regard- 
ing the system's knowledge and the other, its computer 
structure. As regards the knowledge at present incor- 
porated into SEHO, it is planned to extend the medi- 
cine and expert knowledge data bases. For this purpose, 
another expert in homeopathic medicine, likewise a 
member of the pluralist school, will join the research 
team, with a view to adding to the knowledge and 
comparing his approach with that of the former expert. 
With respect o the SEHO's computer structure, 
three basic measures are envisaged. 
• The new knowledge acquisition stage will make it 
possible to identify new rules and new forms of pro- 
cessing and handling the most useful aspects of the 
individual cases. For this stage, it is planned to in- 
corporate an automated knowledge acquisition 
module that will equip the system with the capability 
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of analyzing any new information that comes to light, 
as well as facilitating the knowledge acquisition task. 
There are also plans to equip the final system with 
an intelligent interface capable of selecting the ques- 
tions to be put to the expert. 
• Adapt the user interface to a more flexible graphic 
environment for use by sighted personnel, while the 
present interface will be kept for the blind user. For 
this purpose, the screens of yes/no questions (62 on 
symptoms, 57 on category, and 66 on field charac- 
teristics) will be replaced by 4 multiple choice win- 
dows with a scroll bar (for symptoms, category, and 
field, and to select the important symptoms from 
those chosen). 
The information will be output to an independent 
window controlled by the application, and new phases 
and explanations will be incorporated to make it easier 
to follow the system's logic. 
• With a view to creating an easily extendible and 
reusable expert system, in place of the present 
GURU-based configuration that is difficult to alter, 
the SEHO prototype will be adapted to an object- 
oriented environment by transforming the present 
medicine and knowledge bases and rules into a class 
structure. The CLASER (Set of Open Libraries for 
the Development and Query of Reusable Expert 
Systems) (Garcia, 1993), recently developed at CET- 
TICO in C++, will be employed to this end. 
From experience with other systems, this measure 
should make the future SEHO system approximately 
10 times faster than the present system, in addition to 
the above-mentioned advantages of extendibility and 
reusability. 
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